UBS Group’s Danimer Scientific, Inc. DNMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-539
| Closed | -$9.78K | – | 10680 |
|
|
2024
Q3 | $9.78K | Sell |
539
-2,115
| -80% | -$36.9K | ﹤0.01% | 7769 |
|
|
2024
Q2 | $64K | Sell |
2,654
-1,861
| -41% | -$57.9K | ﹤0.01% | 6492 |
|
|
2024
Q1 | $197K | Sell |
4,515
-28
| -0.6% | -$1.16K | ﹤0.01% | 5864 |
|
|
2023
Q4 | $185K | Buy |
4,543
+868
| +24% | +$47.2K | ﹤0.01% | 5821 |
|
|
2023
Q3 | $304K | Sell |
3,675
-173
| -4% | -$15.7K | ﹤0.01% | 5045 |
|
|
2023
Q2 | $366K | Buy |
3,848
+1,081
| +39% | +$139K | ﹤0.01% | 5078 |
|
|
2023
Q1 | $382K | Sell |
2,767
-386
| -12% | -$35.3K | ﹤0.01% | 4904 |
|
|
2022
Q4 | $226K | Sell |
3,153
-711
| -18% | -$67.3K | ﹤0.01% | 5360 |
|
|
2022
Q3 | $456K | Sell |
3,864
-912
| -19% | -$162K | ﹤0.01% | 4415 |
|
|
2022
Q2 | $871K | Buy |
4,776
+1,352
| +39% | +$246K | ﹤0.01% | 3844 |
|
|
2022
Q1 | $803K | Buy |
3,424
+633
| +23% | +$128K | ﹤0.01% | 4319 |
|
|
2021
Q4 | $952K | Buy |
2,791
+1,823
| +188% | +$1M | ﹤0.01% | 4432 |
|
|
2021
Q3 | $633K | Sell |
968
-4,447
| -82% | -$3.27M | ﹤0.01% | 4548 |
|
|
2021
Q2 | $5.43M | Buy |
5,415
+4,335
| +401% | +$4.32M | ﹤0.01% | 2589 |
|
|
2021
Q1 | $1.63M | Buy |
1,080
+819
| +314% | +$1.33M | ﹤0.01% | 3777 |
|
|
2020
Q4 | $246K | Buy |
+261
| New | +$140K | ﹤0.01% | 5110 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | -$3K | – | 8503 |
|
|
2020
Q2 | $3K | Buy |
+6
| New | +$2.33K | ﹤0.01% | 7568 |
|
Other funds holding DNMR
UBS Group's DNMR Position: Q4 2024 in Review
UBS Group sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 539 shares — an estimated $9.78K sold.
UBS Group first reported a position in DNMR in Q2 2020 and held it in 17 quarters. The position peaked at $5.43M in Q2 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.
- UBS Group reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 539 Danimer Scientific, Inc. shares in Q4 2024, an estimated $9.78K.
- UBS Group first reported a position in Danimer Scientific, Inc. in Q2 2020 and held it in 17 quarters.
- UBS Group's Danimer Scientific, Inc. position peaked at $5.43M in Q2 2021.
- 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.